Enpp1asj-2J/Enpp1+
BALB/cJ-Enpp1asj-2J/GrsrJ
|
calcinosis |
J:215824
|
nephrocalcinosis |
J:215824
|
Enpp1asj-2J/Enpp1asj-2J
BALB/cJ-Enpp1asj-2J/GrsrJ
|
abnormal calcium ion homeostasis |
J:215824
|
abnormal circulating calcium level |
J:215824
|
abnormal circulating mineral level |
J:215824
|
abnormal circulating phosphate level |
J:215824
|
abnormal gait |
J:215824
|
abnormal joint morphology |
J:215824
|
abnormal posture |
J:215824
|
abnormal vibrissa follicle morphology |
J:215824
|
calcified aorta |
J:215824
|
calcified joint |
J:215824
|
calcified skin |
J:215824
|
calcinosis |
J:215824
|
decreased circulating phosphate level |
J:215824
|
decreased joint mobility |
J:215824
|
hunched posture |
J:215824
|
nephrocalcinosis |
J:215824
|
scoliosis |
J:215824
|
Enpp1asj/Enpp1+
C57BL/6J-Enpp1asj/GrsrJ
|
abnormal renal artery morphology |
J:201689
|
decreased circulating phosphate level |
J:201689
|
Enpp1asj/Enpp1asj
C57BL/6J-Enpp1asj/GrsrJ
|
abnormal aorta morphology |
J:201689
|
abnormal auditory tube morphology |
J:251638
|
abnormal carotid artery morphology |
J:201689
|
abnormal coronary artery morphology |
J:201689
|
abnormal elbow joint morphology |
J:174912
|
abnormal gait |
J:174912,
J:201689
|
abnormal kidney arcuate artery morphology |
J:201689
|
abnormal kidney morphology |
J:201689
|
abnormal knee joint morphology |
J:174912
|
abnormal liver vasculature morphology |
J:201689
|
abnormal middle ear morphology |
J:251638
|
abnormal mineral level |
J:201689
|
abnormal resting posture |
J:174912
|
abnormal retina morphology |
J:201689
|
abnormal round window morphology |
J:251638
|
abnormal skin adnexa morphology |
J:201689
|
abnormal snout skin morphology |
J:252837
|
abnormal stapedial artery morphology |
J:251638
|
abnormal tympanic membrane morphology |
J:251638
|
abnormal vibrissa follicle morphology |
J:174912
|
calcified aorta |
J:201689
|
calcified artery |
J:201689
|
calcified retina |
J:201689
|
calcified skin |
J:201689,
J:252837
|
calcinosis |
J:215824,
J:252837
|
conductive hearing loss |
J:251638
|
decreased circulating phosphate level |
J:201689
|
decreased joint mobility |
J:201689
|
impaired hearing |
J:174912
|
increased middle ear goblet cell number |
J:251638
|
increased or absent threshold for auditory brainstem response |
J:251638
|
increased susceptibility to induced morbidity/mortality |
J:201689
|
increased susceptibility to otitis media |
J:251638
|
incudomalleolar fusion |
J:251638
|
joint inflammation |
J:174912
|
middle ear effusion |
J:251638
|
middle ear polyps |
J:251638
|
osteoarthritis |
J:174912
|
osteomyelitis |
J:174912
|
tympanic membrane retraction |
J:251638
|
Enpp1m1Amgn/Enpp1m1Amgn
involves: C3H/HeSnJ * C57BL/6J * Swiss
|
abnormal gait |
J:168664
|
abnormal joint morphology |
J:168664
|
abnormal knee joint morphology |
J:168664
|
abnormal spinal cord morphology |
J:168664
|
calcified aorta |
J:168664
|
calcified artery |
J:168664
|
calcified calcaneal tendon |
J:168664
|
calcified joint |
J:168664
|
calcified tendon |
J:168664
|
decreased bone mass |
J:168664
|
decreased bone mineral content |
J:168664
|
decreased bone mineral density |
J:168664
|
decreased joint mobility |
J:168664
|
exostosis |
J:168664
|
Enpp1tm1Gdg/Enpp1tm1Gdg
involves: 129S1/Sv
|
abnormal adipose tissue morphology |
J:133011
|
abnormal osteoblast physiology |
J:111462
|
abnormal trabecular bone morphology |
J:111462
|
calcified calcaneal tendon |
J:111462
|
calcified intervertebral disk |
J:111462
|
fused joints |
J:111462
|
increased bone ossification |
J:111462
|
Enpp1tm1Gdg/Enpp1tm1Gdg
involves: 129S1/Sv * C57BL/6
|
abnormal cartilage development |
J:110028
|
abnormal motor capabilities/coordination/movement |
J:78590
|
abnormal vascular smooth muscle morphology |
J:110028
|
calcified aorta |
J:110028
|
decreased skin turgor |
J:78590
|
fused joints |
J:78590
|
Enpp1ttw-Ham/Enpp1ttw-Ham
Jcl:ICR-Enpp1ttw-Ham
|
abnormal forelimb joint morphology |
J:250073
|
abnormal hair follicle morphology |
J:250073
|
abnormal hand joint morphology |
J:250073
|
abnormal joint morphology |
J:250073
|
abnormal ligament morphology |
J:250073
|
abnormal nucleus pulposus morphology |
J:250073
|
abnormal outer ear cartilage morphology |
J:250073
|
abnormal posterior longitudinal ligament morphology |
J:250073
|
abnormal spinal cord morphology |
J:250073
|
abnormal vibrissa morphology |
J:250073
|
decreased abdominal adipose tissue amount |
J:250073
|
decreased food intake |
J:250073
|
decreased white fat cell size |
J:250073
|
fused carpal bones |
J:250073
|
fused joints |
J:250073
|
fusion of vertebral bodies |
J:250073
|
premature death |
J:250073
|
vertebral fusion |
J:250073
|
weight loss |
J:250073
|
Enpp1ttw/Enpp1ttw
involves: ICR
|
abnormal axial skeleton morphology |
J:19124,
J:37369
|
abnormal bone mineralization |
J:37369,
J:43357
|
abnormal chondrocyte morphology |
J:19124
|
abnormal chondrocyte proliferation |
J:37369
|
abnormal enthesis morphology |
J:43357
|
abnormal gait |
J:37369
|
abnormal grip strength |
J:19124
|
abnormal intervertebral disk morphology |
J:19124,
J:37369,
J:43357
|
abnormal joint morphology |
J:19124,
J:37369
|
abnormal ligament morphology |
J:19124
|
abnormal posterior longitudinal ligament morphology |
J:43357
|
abnormal skeleton physiology |
J:43357
|
abnormal vertebrae morphology |
J:19124,
J:43357
|
calcified aorta |
J:37369
|
calcified calcaneal tendon |
J:37369
|
calcified intervertebral disk |
J:37369
|
calcified joint |
J:19124,
J:37369
|
calcinosis |
J:37369
|
decreased body weight |
J:43357
|
decreased circulating phosphate level |
J:43357
|
normal
homeostasis/metabolism phenotype |
J:19124
|
increased alkaline phosphatase activity |
J:43357
|
osteoarthritis |
J:19124,
J:37369
|
osteoporosis |
J:37369
|
postnatal growth retardation |
J:37369
|
premature death |
J:37369
|